Importantly, our multivariate analysis unveiled that heightened ALDH1 immunostaining in tumour cells within the ITF served as an independent predictor of diminished survival, collectively underscoring the substantial potential for ALDH1 as an important CSC driver in OSCC carcinogenesis, and progression. The gene discussed is ALDH1A1; the disease is neoplasm.